Triple-Wavelength Fractional Resurfacing to Treat Every Layer in a Single Pass

Fully ablative resurfacing with either CO₂ or erbium:YAG has long been the reference standard for laser skin resurfacing, capable of dramatic improvement in rhytids, texture, dyschromia, and actinic damage in a single session.¹ That corrective power, however, is associated with prolonged recovery, obligate wound care, and protracted erythema, with an associated risk of dyspigmentation and scarring that limits use to experienced clinicians and well-selected patients.¹

Fractionally ablative and non-ablative approaches were developed for safer and easier improvements in skin.² By treating only a fraction of the skin per pass and, in the nonablative case, coagulating rather than vaporizing tissue, they preserve intervening reservoirs of untreated skin that accelerate healing—shorter recovery, lower dyspigmentation risk, and a tolerability that opens resurfacing to a far broader range of patients and skin types. The tradeoff is efficacy per treatment: these modalities improve skin quality but typically require multiple sessions and cannot match the single-session corrective power of fully ablative resurfacing.²

Multiple-wavelength resurfacing devices have since emerged to narrow that gap. In 2014, the first hybrid fractional laser combined an ablative 2940-nm wavelength with a non-ablative 1470-nm wavelength in a single device.³ By depositing an ablative and a non-ablative beam into the same microthermal zone, it corrected surface and depth together in one pass with a favorable recovery profile. Its corrective capability exceeded that of purely non-ablative devices while retaining much of the easier recovery and safety of fractional treatment. One zone of the skin, however, remained under-addressed: with ablation kept superficial and the nonablative wavelength reaching deep into the reticular dermis at 300 µm to 700 µm, the intervening pigment-and-polish zone of the deep epidermis and superficial dermis fell between the two beams.³

Triple-wavelength resurfacing is the deliberate engineering of a solution to that gap. It integrates three independently controlled wavelengths—2940-nm Er:YAG, 1927-nm diode, and 1470-nm diode—into one synchronized treatment, each rebuilt with substantially greater capacity than its standalone predecessor (Figure 1). The 1927-nm diode is adjustable across a wide range, from 5 mJ and 5% density to 40 mJ and 40% density. The 1470-nm diode is adjustable from 300 µm to 700 µm in depth at 5% to 40% density, with available power increased from 30 w to 50 w; because penetration across the reticular dermis is already sufficient, the added power is spent not on reaching deeper depths but on speed, yielding up to approximately 50% faster delivery at the deepest settings and a full-face treatment in 8 to 12 minutes. The erbium channel can be unbound from the others and driven to a fully ablative endpoint at a maximum depth of 150 µm. The ability to either use one, two, or all three of these wavelengths at a time produces a wide range of treatment intensity and corrective capability from a single platform.

WHY THREE WAVELENGTHS ACT 
IN CONCERT

Although water is the dominant chromophore for all three wavelengths, its absorption coefficient differs at each, resulting in differential depth of penetration for each. The three therefore act on distinct, largely non-overlapping tissue compartments, and their effects are complementary rather than redundant: each wavelength drives a discrete photothermal response in the compartment it reaches, and the combined treatment addresses several tissue planes in parallel that would otherwise require separate devices or sequential sessions with multiple devices.

2940 nm (Er:YAG) — controlled ablation. With the highest water absorption of the three, the erbium beam vaporizes tissue within a shallow zone and leaves minimal residual thermal injury, refining surface texture and softening fine rhytids while permitting rapid re-epithelialization from the preserved adnexal and untreated reservoirs.

1927 nm (diode) — the pigment and tone wavelength. Shallowly absorbed, the thulium beam is nonablative at lower fluence and subablative at higher fluence, coagulating epidermal and junctional melanin to reduce lentigines and dyschromia and to improve epidermal clarity, targeting the deep-epidermal and superficial-dermal zone that lies below the reach of surface ablation and above that of the deep diode.^4-6 At its maximum fluence of 40 mJ, histology has revealed penetration approaching 300 µm.

1470 nm (diode) — deep dermal remodeling. Adjustable from 300 µm to 700 µm, the diode deposits columns of coagulation within the reticular dermis that initiate a wound-healing response and subsequent neocollagenesis and elastin remodeling. This deep dermal stimulus is the basis for durable correction of atrophic scarring, established rhytids, and the architectural changes of chronologic and actinic aging, in which lasting improvement depends on remodeling of the dermal matrix rather than the epidermis alone.

Because the three targets occupy different depths, their contributions are additive rather than competitive. Pairing the 1927-nm and 1470-nm beams, for instance, addresses pigment residing in both the epidermis and the deeper dermis while simultaneously remodeling the supporting dermal matrix beneath it.

COORDINATED DELIVERY
AND ADDITIVE DENSITY

In combination treatment, the 1927-nm beam fires on its own pulses, never coincident with the others, so its contribution to total density is purely additive. The 2940-nm beam is always deposited coincidentally with a 1470-nm pulse—each ablative pulse placed directly over a deeper coagulating column—so the surface is never treated in isolation from the dermis beneath it. Because erbium density is set at or below the diode density, the remaining 1470-nm pulses fire alone. A standard pass is therefore composed of three pulse types: thulium alone, coincident erbium-on-diode, and diode alone.

A single exception is a dedicated mode in which the erbium is unbound from the diode and fired alone. It can be driven deeper and at higher density than in combination and rolled across a region with confluent passes—a rolling, fractionally ablative use of erbium capable of producing a focal, fully ablative result over a discrete lesion without committing the surrounding field to full-field ablation. Its application is illustrated in the second case below.

TAILORING THE TREATMENT 
TO THE PATIENT

Because each wavelength is independently controlled, treatment is constructed for the individual rather than selected from a fixed program. Erbium and the deep diode lead in textural and scar-driven cases; thulium leads for pigment and photodamage; all three are balanced for global rejuvenation. The same three beams, weighted differently, span the full range of resurfacing indications, from light prejuvenation to dramatic correction. Regional control follows the same logic within one session: the lateral cheeks may be treated more aggressively than the central face, the neck more conservatively, adjusted plane by plane and region by region.

CASE 1: MIXED-TYPE MELASMA IN FITZPATRICK III–IV SKIN

A woman of East Asian descent (Fitzpatrick IV) presented with mixed epidermal and dermal melasma across the left malar and lateral cheek (Figure 2). This mixed-type pattern is both the most treatment-resistant form of the condition and the highest-risk for post-inflammatory hyperpigmentation (PIH), the complication that makes most resurfacing hazardous in this population.^7,8 The treatment objective was to address pigment seated in two planes without provoking rebound pigmentation.

Figure 2.

Figure 3.

Figures 2 and 3. Mixed-type melasma before and following a single triple-wavelength treatment. Conservative, pigment-weighted parameters achieved substantial clearance of both epidermal and dermal pigment without post-inflammatory hyperpigmentation in Fitzpatrick IV skin.

A triple-wavelength device (HALO® TRIBRID™; Sciton, Inc.) was utilized, and all three wavelengths were used in a single session, weighted toward pigment and parameterized conservatively for skin type. The 1927-nm diode was set at 30 mJ and 10% density to target epidermal and junctional pigment. The 1470-nm diode was set at 500 µm and 10% density to reach the dermal component and remodel the supporting matrix. The 2940-nm erbium was set at 50 µm and 6% density, deposited coincidentally with the diode for light surface refinement. Because the erbium rode the diode pulse, total additive density was 20%—the 10% thulium contribution plus the 10% coincident erbium-diode stack. Figure 3 shows the result.

This case demonstrates the central advantage of independent depth control: pigment occupying both the epidermis and the dermis was addressed in one session, at parameters conservative enough to protect a high-risk skin type, by assigning each plane to the wavelength suited to it rather than escalating the fluence of any single beam.

CASE 2: DIFFUSE PHOTODAMAGE
WITH A FOCAL EXTENSIVE SEBORRHEIC KERATOSIS

A 67-year-old woman (Fitzpatrick I–II) presented with diffuse facial photodamage—mottled dyschromia, solar lentigines, fine-to-moderate rhytids, telangiectasia, and textural roughness—together with a single extensive macular seborrheic keratosis across the left lateral cheek and preauricular skin (Figure 4 and Figure 5). The case required two distinct objectives in one session: a field treatment for the diffuse photodamage and deep dermal remodeling, and a focal, ablative-grade clearance of the keratosis that conventional management would have addressed only with full-field ablative resurfacing.

Figure 4.

Figure 5.

Figures 4 and 5. Baseline images of diffuse photodamage with a focal extensive seborrheic keratosis prior to a single session combining a full-face triple-wavelength field treatment with a focal rolling-ablative erbium step over the keratosis. Recovery shown in Figures 6-10.

The field treatment combined all three wavelengths of the aforementioned device, weighted toward dermal remodeling given the degree of photoaging. The 1470-nm diode was set at 600 µm and 30% density for deep collagen stimulation; the 1927-nm diode at 30 mJ and 25% density for the diffuse surface pigment and photodamage; and the 2940-nm erbium at 100 µm and 6% density, coincident with the diode, for surface refinement. Total additive density across the field was 55%—the 25% thulium contribution plus the 30% coincident erbium-diode stack.

The keratosis was then treated as a focal step in the dedicated erbium-only mode. The 2940-nm laser was fired alone and rolled across the lesion with confluent passes to 70% density, producing a fully ablative endpoint over the keratosis alone while the surrounding face remained fractional. The lesion cleared completely. Achieving the same result by conventional means would have required full-field ablative resurfacing of the region, with injected local anesthesia, up to 2 weeks of open wound care, and erythema persisting for months.

Recovery, by contrast, was straightforward. The treatment was performed under topical anesthetic alone, with moisturizer-only aftercare and no open wound care. The course followed a dry, fractional sloughing rather than an open wound: dense microcrust through days 2 to 4 (Figures 6 and 7), lifting through day 6 (Figure 8), near-resolved by day 8 (Figure 9), and healed by day 14 (Figure 10), with no delayed or rebound erythema and no post-inflammatory hyperpigmentation. The epidermis was never denuded as full-field ablation leaves it; bronzing and sloughing proceeded with the surface intact beneath.

Figure 10.

Figures 6 through 10. The patient's recovery course following the combined field and focal-ablative treatment, documented at days 2, 4, 6, 8, and 14. Despite an ablative-grade endpoint over the keratosis, the course was a dry fractional slough under topical anesthetic and moisturizer-only aftercare, without open wound care, delayed erythema, or dyspigmentation.

This case illustrates what independent wavelength control makes possible: the single region requiring full ablation received it, applied focally through the dedicated erbium mode, while the remainder of the face was treated fractionally—decoupling an ablative endpoint from the morbidity that full-field ablative resurfacing of the same lesion would have imposed.

CONSISTENCY, SAFETY, 
AND WORKFLOW

Real-time thermal feedback, in which nonablative output is continuously adjusted to the patient’s skin temperature, narrows the variability that otherwise accumulates across a full-face treatment and reduces the risk of thermal stacking.

We can safely treat all Fitzpatrick types from I to VI with this technology. For higher Fitzpatrick types, conservative density, careful attention to thulium and deep-wavelength energy, and appropriate peri-procedural pigment management remain the prudent course. We deliver the energy at a lower percentage per pass for these patients.

Integrated cooling and smoke evacuation, a lightweight handpiece, and faster deep-wavelength delivery contribute to the 8- to 12-minute full-face treatment time.

CONCLUSION

The value of triple-wavelength resurfacing lies in the independent control of three complementary depths, which allows treatment to be matched to the individual patient. Texture, pigment, and dermal structure can be corrected concurrently, weighted to the dominant concern. Where indicated, a focal ablative endpoint can be reached without field-wide morbidity. For indications that have historically required separate devices, staged appointments, or the recovery burden of full-field ablation, a single adjustable platform can now accomplish the work in one session.

Disclosure: Dr. Ibrahim is an advisor, speaker, and equity holder for Sciton, Inc.